Traditional SCORE-based health check fails to identify individuals who develop acute myocardial infarction

Danish Medical Journal

Volumn 60, Issue 5, 2013, Pages

  Mortensen, Martin B ^a   Sivesgaard, Kim ^b   Jensen, Helle K ^a   Comuth, Willemijn ^c   Kanstrup, Helle ^a   Gotzsche, Ole ^a   May, Ole ^c   Bertelsen, Jette ^b   Falk, Erling ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RANDERS REGIONAL HOSPITAL   (Denmark)

^c HERNING HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREDICTIVE VALUE; RISK ASSESSMENT; SCORE; SCORING SYSTEM; SENSITIVITY ANALYSIS; AGE; BLOOD; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCEDURES; RISK FACTOR; SEX DIFFERENCE; SMOKING; VERY ELDERLY; HEART INFARCTION; METHODOLOGY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CHOLESTEROL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84877152283     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. NHS Health Check: vascular risk assessment and management best practice guidance. The National Health Service (NHS) in England 2009. www.healthcheck.nhs.uk/ (3 Apr 2013).
2. Baggrund for Hjerteforeningens forebyggelsespolitik 2009: evidensbaserede, konkrete og omkostningseffektive forslag til forebyggelse af hjertekarsygdom. Copenhagen: Hjerteforeningen, 2008. www.hjerteforeningen.dk/files/Rapporter_mm/HFs_Forebyggelsespolitik_2009.pdf (3 Apr 2013).
3. Pedersen KM, Bech M, Vrangbæk K. The Danish Health Care System: an analysis of strengths, weaknesses, opportunities and threats. Consensus Report 978-87-92795-00-7 from the Copenhagen Consensus Center, 2009. www.copenhagenconsensus.com/sites/default/files/ConsensusReportDanishHealth_final.pdf (3 Apr 2013).
4. Perk J, De Backer G, Gohlke H et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012;33:1635-1701.
5. Standard SCORE charts. www.escardio.org/communities/EACPR/Documents/score-charts-2012.pdf (3 Apr 2013).
6. HDL-adjusted SCORE charts. www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-dyslipidemias-addenda.pdf (3 Apr 2013)
7. Ebrahim S, Taylor F, Ward K et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;(1):CD001561.
8. Jørgensen T. Screening followed by lifestyle intervention had no effect on cardiovascular morbidity and mortality: final result of the Inter99 study [in Danish]. Research Centre for Prevention and Health, 2012. www.regionh.dk/fcfs/topmenu/Nyheder/Nyhedsarkiv/Screening+i+normalbefolkningen+har+ingen+effekt.htm (3 Apr 2013).
9. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24: 1601-1610.
10. Heidenreich PA, Trogdon JG, Khavjou OA et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-944.
11. Nyhedsbrev: Fokus på kronikerindsatsen. Danish Health and Medicines Authority, 2011. www.sst.dk/Nyhedscenter/Nyhedsbreve/Fokus%20paa%20kronikerindsatsen/Nr_3_nov_11.aspx?item={727E3709-A036-4FCF-A107-07A59720D829} (3 Apr 2013).
12. Wisloff T, Nordheim OF, Halvorsen S et al. Costs and life year gained with pharmaceutical primary prevention of cardiovascular disease [in Norwegian]. Report no. 34 from the Norwegian Knowledge Centre for the Health Services. Oslo, 2008. www.kunnskapssenteret.no/Publikasjoner/4786.cms (3 Apr 2013).
13. Lazar LD, Pletcher MJ, Coxson PG et al. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation 2011;124:146-153.
14. Steinberg D, Grundy SM. The case for treating hypercholesterolemia at an earlier age: moving toward consensus. J Am Coll Cardiol 2012;60:2640-2642.
15. Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-590.
16. Diederichsen AC, Sand NP, Nørgaard B et al. Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Prev Cardiol 2012;19:558-564.
17. Sachdeva A, Cannon CP, Deedwania PC et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 2009;157:111-7. e2.
18. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006;355:2615-2617.
19. Sillesen H, Falk E. Why not screen for subclinical atherosclerosis? Lancet 2011;378:645-646.
20. Greenland P, Alpert JS, Beller GA et al. 2010 ACCF/AHA Guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50-e103.
21. Pitt B, Loscalzo J, Ycas J et al. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 2008;51:1440-1445.